Barentz announces acquisition of spice specialists Royal Polak and De Weerd

Barentz International, a leading global distributor of life science ingredients has expanded its activities in taste and nutrition even further with the acquisition of two leading, Dutch-based spice specialists: Royal Polak Spices - a leading  business-to-business cinnamon specialist, and De Weerd Spices - specialist in natural taste development and innovation for the European food industry. The acquisition of both companies is aligned with Barentz’ strategy to become a global leader in the life science industries, and to further develop taste and nutrition knowledge, products and services within the Human Nutrition sector. The completion of the transaction is subject to customary closing conditions, including regulatory approval.                                                                                                                

Highlights:

• Royal Polak Spices and De Weerd Spices are both Dutch-based, knowledge-driven spice specialists. Both companies have a qualitative and solid customer base in the European food industry.
• With over 150 years of experience, Royal Polak Spices is considered the number one cinnamon specialist in the world.
• De Weerd Spices specifically adds value in natural taste development and innovation, with a focus on meat, snacks and vegetarian products.
• Both companies fit seamlessly into Barentz’ overall product portfolio, and will be given excellent growth opportunities in the USA and South America.

Mr. Jac Sars, the owner of Royal Polak and De Weerd has become a Board Member in the Barentz Group, with the role of strategic advisor.

“Mr. Jac Sars has a tremendous amount of experience, and we are pleased that he can guide us to continue the excellence and growth of both companies,” explained Hidde van der Wal, CEO of Barentz.

According to Mr. Sars, it has been a difficult decision to sell off the shares. “But it gives a very good feeling that Barentz can help to grow and further internationalize the business. Barentz is well-known, has the same philosophy and entrepreneurial DNA as we do, and is the best possible new shareholder to continue a great new future for all the stakeholders,” he remarked.

The acquisitions bring great opportunities. “Both companies do fit very well in the Barentz product portfolio,” added van der Wal. “We have no conflicts of interest, and De Weerd as well as Royal Polak are complementary to our life science activities. Their application labs further strengthen our customer services. And we also see excellent new opportunities to grow in other parts of the world like the USA and South America. It is a dream combination that enables us to offer quality and expertise to our customers.”